Inventor
VOGELS RONALD
NL51 patents
⚠️ This page may combine multiple inventors who share the name “VOGELS RONALD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CRUCELL HOLLAND BV
32 patentsUS7270811B2Sep 18, 2007
Serotype of adenovirus and uses thereof
CRUCELL HOLLAND BV112 citations98
US6974695B2Dec 13, 2005
Complementing cell lines
CRUCELL HOLLAND BV85 citations98
US6492169B1Dec 10, 2002
Complementing cell lines
CRUCELL HOLLAND BV113 citations98
US6913922B1Jul 5, 2005
Serotype of adenovirus and uses thereof
CRUCELL HOLLAND BV86 citations97
US6869794B2Mar 22, 2005
Complementing cell lines
CRUCELL HOLLAND BV47 citations96
US7820440B2Oct 26, 2010
Means and methods for producing adenovirus vectors
CRUCELL HOLLAND BV20 citations93
US7468181B2Dec 23, 2008
Means and methods for the production of adenovirus vectors
CRUCELL HOLLAND BV25 citations93
US6670188B1Dec 30, 2003
Packaging systems for human recombinant adenovirus to be used in gene therapy
CRUCELL HOLLAND BV25 citations93
US8052967B2Nov 8, 2011
Stable adenoviral vectors and methods for propagation thereof
CRUCELL HOLLAND BV16 citations92
US7906113B2Mar 15, 2011
Serotype of adenovirus and uses thereof
CRUCELL HOLLAND BV19 citations92
US7749493B2Jul 6, 2010
Chimeric adenoviruses
CRUCELL HOLLAND BV19 citations92
US7344883B2Mar 18, 2008
Complementing cell lines
CRUCELL HOLLAND BV11 citations92
US6905678B2Jun 14, 2005
Gene delivery vectors with cell type specificity for mesenchymal stem cells
CRUCELL HOLLAND BV32 citations92
US8012467B2Sep 6, 2011
Multivalent vaccines comprising recombinant viral vectors
CRUCELL HOLLAND BV18 citations91
US6869936B1Mar 22, 2005
Means and methods for fibroblast-like or macrophage-like cell transduction
CRUCELL HOLLAND BV19 citations91
US9452211B2Sep 27, 2016
Influenza virus vaccines and uses thereof
CRUCELL HOLLAND BV27 citations90
US7285265B2Oct 23, 2007
Stable adenoviral vectors and methods for propagation thereof
CRUCELL HOLLAND BV25 citations89
US7598078B2Oct 6, 2009
Settings for recombinant adenoviral-based vaccines
CRUCELL HOLLAND BV13 citations87
US6803234B2Oct 12, 2004
Gene delivery vectors with cell type specificity for primary human chondrocytes
CRUCELL HOLLAND BV13 citations84
US6929946B1Aug 16, 2005
Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
CRUCELL HOLLAND BV12 citations83
US8852595B2Oct 7, 2014
Human binding molecules capable of binding to and neutralizing influenza B viruses and uses thereof
CRUCELL HOLLAND BV8 citations82
US8834881B2Sep 16, 2014
Human binding molecules capable of binding to and neutralizing influenza B viruses and uses thereof
CRUCELL HOLLAND BV4 citations82
US7604960B2Oct 20, 2009
Transient protein expression methods
CRUCELL HOLLAND BV11 citations82
US7037716B2May 2, 2006
Packaging systems for human recombinant adenovirus to be used in gene therapy
CRUCELL HOLLAND BV5 citations74
US7250293B2Jul 31, 2007
Complementing cell lines
CRUCELL HOLLAND BV4 citations73
US9228205B2Jan 5, 2016
Complementing cell lines
CRUCELL HOLLAND BV1 citations63
US7968087B2Jun 28, 2011
Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
CRUCELL HOLLAND BV3 citations62
US7816104B2Oct 19, 2010
Packaging cells for recombinant adenovirus
CRUCELL HOLLAND BV5 citations62
US7238528B2Jul 3, 2007
Means and methods for fibroblast-like or macrophage-like cell transduction
CRUCELL HOLLAND BV5 citations62
US9200064B2Dec 1, 2015
Human binding molecules capable of binding to and neutralizing influenza B viruses and uses thereof
CRUCELL HOLLAND BV2 citations61
US9005621B2Apr 14, 2015
Human binding molecules capable of binding to and neutralizing influenza B viruses and uses thereof
CRUCELL HOLLAND BV2 citations61
US9593159B2Mar 14, 2017
Human binding molecules capable of neutralizing influenza A viruses of phylogenetic group 1 and phylogenetic group 2 and influenza B viruses
CRUCELL HOLLAND BV1 citations46
JANSSEN VACCINES & PREVENTION BV
6 patentsUS10370435B2Aug 6, 2019
Binding molecules directed against influenza hemagglutinin and uses thereof
JANSSEN VACCINES & PREVENTION BV6 citations80
US10703804B2Jul 7, 2020
Binding molecules directed against influenza hemagglutinin and uses thereof
JANSSEN VACCINES & PREVENTION BV1 citations69
US9969778B2May 15, 2018
Influenza virus vaccines and uses thereof
JANSSEN VACCINES & PREVENTION BV4 citations69
US11136379B2Oct 5, 2021
Binding molecules directed against influenza hemagglutinin and uses thereof
JANSSEN VACCINES & PREVENTION BV0 citations59
US11964007B2Apr 23, 2024
Methods and compositions for heterologous repRNA immunizations
JANSSEN VACCINES & PREVENTION BV0 citations57
US11235051B2Feb 1, 2022
Methods and compositions for heterologous repRNA immunizations
JANSSEN VACCINES & PREVENTION BV1 citations57
VOGELS RONALD
3 patentsGALAPAGOS GENOMICS NV
2 patentsUS6340595B1Jan 22, 2002
High throughput screening of gene function using adenoviral libraries for functional genomics applications
GALAPAGOS GENOMICS NV59 citations93
US7029848B2Apr 18, 2006
High throughput screening of gene function using libraries for functional genomics applications
GALAPAGOS GENOMICS NV37 citations89
HAVENGA MENZO JANS EMCO
2 patentsINTROGENE BV
1 patentGALAPAGOS GEONOMICS N V
1 patentKWAKS THEODORUS HENDRIKUS JACOBUS
1 patentVAN BEEK JOZEF THOMAS MARTINUS
1 patentBOUT ABRAHAM
1 patentShowing the top 50 of 51 patents by PatentIndex Score.